A few days ago, the FDA issued a clinical trial for the company’s research drug application for the company’s gene therapy VY-HTT01 for the treatment of Huntington’s disease.
A few days ago, the FDA released the clinical application for a new research drug of gene therapy vy-htt01 for the treatment of Huntington's disease<br>